Literature DB >> 26957397

The Kidney in Critical Cardiac Disease: Proceedings From the 10th International Conference of the Pediatric Cardiac Intensive Care Society.

David S Cooper1, Rajit K Basu2, Jack F Price3, Stuart L Goldstein4, Catherine D Krawczeski5.   

Abstract

The field of cardiac intensive care continues to advance in tandem with congenital heart surgery. The focus of intensive care unit care has now shifted to that of morbidity reduction and eventual elimination. Acute kidney injury (AKI) after cardiac surgery is associated with adverse outcomes, including prolonged intensive care and hospital stays, diminished quality of life, and increased long-term mortality. Acute kidney injury occurs frequently, complicating the care of both postoperative patients and those with heart failure. Patients who become fluid overloaded and/or require dialysis are at high risk of mortality, but even minor degrees of AKI portend a significant increase in mortality and morbidity. Clinicians continue to seek methods of early diagnosis and risk stratification of AKI to prevent its adverse sequelae. Previous conventional wisdom that survivors of AKI fully recover renal function without subsequent consequences may be flawed.
© The Author(s) 2016.

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; congenital heart disease; congenital heart surgery; fluid overload; renal replacement therapy

Mesh:

Year:  2016        PMID: 26957397     DOI: 10.1177/2150135115623289

Source DB:  PubMed          Journal:  World J Pediatr Congenit Heart Surg        ISSN: 2150-1351


  2 in total

1.  Acute Kidney Injury and Fluid Overload in Pediatric Cardiac Surgery.

Authors:  Michael A Carlisle; Danielle E Soranno; Rajit K Basu; Katja M Gist
Journal:  Curr Treat Options Pediatr       Date:  2019-08-28

2.  Association of Preoperative Diuretic Use With Early Acute Kidney Injury in Infants With Biventricular Hearts Following Cardiac Surgery.

Authors:  Steven L Rathgeber; Adrija Chakrabarti; Eva Kapravelou; Nicole Hemphill; Christine Voss; Cherry Mammen; Peter Skippen; Kevin C Harris
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.